Markers such as N-cadherin, vimentin, and fibronectin rose in the transformed clones (Figure 7(d)), implying that the combination of loss of RAB25 and H-RAS61L overexpression was driving immortal HMEC toward a mesenchymal-like, stem cell-enriched tumor. The gene discussed is CDH2; the disease is neoplasm.